MedTrace Logo

Treatment of Insertional Achilles Tendinopathy by Hyaluronic Acid Injection

NCT02368561 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-02-23

No results posted yet for this study

Summary

A pilot study of the effects of 3 retro-calcaneal hyalin G-F 20 injection on the clinical and radiological changes in 20 adult patients with changes in insertional achilles tendinopathy.

Conditions

  • Insertional Achilles Tendinitis

Interventions

DRUG

Injection of Hyaluronic Acid -" SYNVISC" (hylan G-F 20)

US guided weekly injection of sodium hyaluronate administered for 3 week in adult subjects with insertional achilles tendinopathy

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • Meir Nyska, Prop · head of orthopedic department

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-01-31
Completion
2016-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02368561 on ClinicalTrials.gov